Future trends in outsourcing

| February 20, 2018

article image
As part of our Spotlight on future trends in outsourcing, we carried out a survey, which was completed by a number of CRO, Pharma & Biotecth leaders within the industry, on various aspects on outsourcing. The results of the survey can be seen in this infographic. In 2018, companies currently outsourcing less than 40% of their bioanalytical work will decrease by 14% In 2018, companies currently outsourcing more than 60% of bioanalytical work will increase by 11%.

Spotlight

Devon Health Services

Devon Health Services, Inc., (www.devonhealth.com) is a regional Preferred Provider Organization (PPO) network in Pennsylvania, New Jersey and Delaware. The company works with health insurance payers, third-party administrators (TPA), self-administered organizations, and healthcare providers to offer increased access to quality healthcare at affordable contract rates.

OTHER ARTICLES

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | March 4, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 4, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 4, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

Devon Health Services

Devon Health Services, Inc., (www.devonhealth.com) is a regional Preferred Provider Organization (PPO) network in Pennsylvania, New Jersey and Delaware. The company works with health insurance payers, third-party administrators (TPA), self-administered organizations, and healthcare providers to offer increased access to quality healthcare at affordable contract rates.

Events